IL23A and psoriasis: It was found that MDSCs from psoriasis patients paradoxically promoted Th17 responses by enhancing Th17 cell differentiation, increasing production of IL-23, IL-1β, and CCL4, while showing reduced expression of PD-1 and PD-L1 and failing to generate Tregs, thereby disrupting T cell homeostasis [134].